Meeting
2014 ASCO Quality Care Symposium
Outcomes in stage I non-small cell lung cancer following the introduction of stereotactic body radiotherapy in Alberta, Canada.
Authors
Marc Kerba
Tom Baker Cancer Centre, Calgary, AB, Canada
Marc Kerba, Zsolt Gabos, Sunita Ghosh, Hongwei Liu, Harold Y. Lau, Barbara Roberts
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Science of Quality and Cost, Value, and Policy in Quality
Track
Science of Quality,Cost, Value, and Policy in Quality
Sub Track
Studies Using Registries or Combining Large Databases
Citation
J Clin Oncol 32, 2014 (suppl 30; abstr 306)
DOI
10.1200/jco.2014.32.30_suppl.306
Abstract #
306
Poster Bd #
G22
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Stereotactic ablative radiotherapy with nivolumab for early-stage operable non-small cell lung cancer: A phase 2 study.
First Author: Gustavo Schvartsman
Poster
2023 ASCO Annual Meeting
Long-term outcomes of single and five fraction schedules of stereotactic body radiation therapy for early-stage central or peripheral NSCLC: Neither fractionation nor location matter?
First Author: Karen Huang
Poster
2022 ASCO Annual Meeting
Dose intensity and outcomes of VDC/IE chemotherapy for adolescent and adult patients with Ewing’s family sarcoma.
First Author: Danielle Klingberg
Poster
2021 ASCO Annual Meeting
Surgical outcomes for early-stage non-small cell lung cancer at facilities with stereotactic body radiation therapy programs.
First Author: Yusef Syed